Skip to content
Search

Latest Stories

No further price concessions for December, DHSC confirms

pharmacy.biz Staff
By pharmacy.biz StaffJan 02, 2020
pharmacy.biz Staff
See Full Bio

The Department of Health and Social Care (DHSC) has confirmed that the price concession announcement made on December 20, 2019 is final for the month and no further concessions will be granted.

The complete list, revealed by PSNC, is as follows:

DrugPack sizePrice Concession
Alverine 60mg capsules100£8.35
Amiloride 5mg tablets28£19.20
Cefalexin 125mg/5ml oral suspension100ml£1.95
Cefalexin 250mg/5ml oral suspension100ml£2.25
Co-careldopa 12.5mg/50mg tablets90£12.25
Co-careldopa 25mg/100mg tablets100£10.99
Colecalciferol 1,000unit capsules30£10.00
Cyclizine 50mg/1ml solution for injection ampoules5£11.98
Desmopressin 200microgram tablets30£19.85
Dexamfetamine 5mg/5ml oral solution sugar free500ml£381.63
Diclofenac sodium 75mg modified-release tablets56£9.70
Diclofenac sodium 100mg modified-release tablets28£10.40
Frovatriptan 2.5mg tablets6£11.91
Hydroxyzine 10mg tablets84£2.45
Hydroxyzine 25mg tablets28£0.97
Imipramine 25mg tablets28£2.99
Indapamide 2.5mg tablets28£2.50
Indoramin 20mg tablets60£10.64
Irbesartan 75mg tablets28£4.06
Irbesartan 150mg tablets28£7.09
Irbesartan 300mg tablets28£6.93
Irbesartan 300mg / Hydrochlorothiazide 12.5mg tablets28£14.31
Lamotrigine 25mg dispersible tablets sugar free56£13.31
Lamotrigine 100mg dispersible tablets sugar free56£9.85
Levetiracetam 250mg tablets60£5.75
Levetiracetam 500mg tablets60£9.92
Levetiracetam 1g tablets60£10.99
Lymecycline 408mg capsules28£5.11
Meloxicam 7.5mg tablets30£3.45
Meloxicam 15mg tablets30£5.30
Memantine 10mg tablets28£4.00
Memantine 20mg tablets28£8.86
Mirtazapine 15mg tablets28£2.61
Mirtazapine 30mg tablets28£3.69
Mirtazapine 45mg tablets28£4.49
Mometasone 50micrograms/dose nasal spray140 dose£4.42
Montelukast 5mg chewable tablets sugar free28£1.86
Nefopam 30mg tablets90£19.79
Nifedipine 5mg capsules90£51.95
Nifedipine 10mg capsules90£65.63
Nifedipine 10mg modified-release tablets56£9.23
Nitrazepam 5mg tablets28£2.64
Nitrofurantoin 50mg tablets28£11.87
Nitrofurantoin 100mg tablets28£9.44
Oxytetracycline 250mg tablets28£5.35
Pizotifen 500microgram tablets28£1.80
Pizotifen 1.5mg tablets28£5.98
Propranolol 40mg tablets28£1.35
Quetiapine 25mg tablets60£2.70
Quinine sulfate 300mg tablets28£9.02
Ranitidine 150mg tablets60£4.15
Ranitidine 300mg tablets30£4.95
Rivastigmine 1.5mg capsules28£3.57
Rivastigmine 3mg capsules28£3.95
Sodium fluoride 0.05% mouthwash sugar free250ml£1.85
Tamoxifen 20mg tablets30£4.71
Tetracycline 250mg tablets28£4.79
Tizanidine 2mg tablets120£12.00
Trihexyphenidyl 2mg tablets84£9.08
Venlafaxine 37.5mg tablets56£7.18
Venlafaxine 75mg tablets56£13.97
Zolpidem 5mg tablets28£1.71
price concessions

Related News

Kelso Pharma continues expansion with £140M funding boost
News

Kelso Pharma secures over £140m of acquisition funding

Community pharmacist accessing GP Connect Access Record on Cegedim Rx platform
News

Cegedim Rx activates GP Connect Access Record

Prepayment certificates helped patients avoid £837M in prescription fees, NHSBSA analysis reveals
News

Prepayment certificates helped patients avoid £837M in prescription fees, NHSBSA analysis reveals

Three pharmacists named in NIHR’s latest cohort of senior investigators
News

Three pharmacists appointed as NIHR senior investigators

More For You

Vaccine-preventable infections costing UK billions

Effective interventions are needed to prevent hospitalisations

Vaccine-preventable infections costing UK billions

Effective interventions are having a positive impact but more needs to be done to combat vaccine-preventable infections after data revealed today showed that it accounted for 20 per cent of hospital bed usage in the UK between 2023 to 2024 at a cost of almost £6 billion.

The return of social mixing, international travel and migration following the COVID-19 pandemic have contributed to the rise in both endemic disease and vaccine-preventable infections, according to the UK Health Security Agency's (UKHSA).

Keep ReadingShow less
Economic analysis of pharmacy finances will be published ‘imminently’ - Stephen Kinnock

Stephen Kinnock also confirms that the outcome of the negotiations with CPE will be announced "very soon."

parliamentlive.tv

NPA collective action “premature, unnecessary and detrimental to patients” - Stephen Kinnock

Health Minister Stephen Kinnock has announced that the government will be releasing the independent economic analysis of pharmacy finances “imminently.”

Responding to a question from shadow health minister Dr. Luke Evans in Parliament today (25), Kinnock criticised the National Pharmacy Association’s (NPA) collective action as “premature, unnecessary, and detrimental to community pharmacy patients.”

Keep ReadingShow less
NPA members are expected reduce opening hours and services from next week

NPA members are expected reduce opening hours and services from next week

Pic credit: iStock

NPA will become more “militant” as wait for pharmacy contract goes on

The government has been warned by the National Pharmacy Association (NPA) that community pharmacy will not back down from collective action and reducing opening hours from April 1st.

NPA board member, Ashley Cohen, told LBC today that the sector was in a "desperate situation" and that the representative body will do “whatever we can to protect our sector”.

Keep ReadingShow less
Community pharmacy needs investment and support to deliver neighbourhood health, says CCA chief

Community pharmacies see patients more than anyone else in the primary care system.

Getty Images

Community pharmacy key to neighbourhood health, but investment needed, says CCA chief

Community pharmacies can play a vital role in delivering a ‘neighbourhood health service’, provided they receive the necessary investment and support, according to Malcolm Harrison, chief executive of the Company Chemists’ Association (CCA).

Harrison's comments come in response to a new report from think tank Reform, titled Designing a Neighbourhood Health Service, which outlines key principles for achieving the government's vision of a more community-focused healthcare system.

Keep ReadingShow less
Mike Hewitson, superintendent pharmacist & managing director of Beaminster Pharmacy

Mike Hewitson elected as NPA board member for England

Mike Hewitson elected as NPA board member for England: New term begins April

Mike Hewitson, superintendent pharmacist & managing director ofBeaminster Pharmacy, has been elected as the next National Pharmacy Association (NPA) board member for England.

Since 2023, Hewitson has served as chair of Community Pharmacy Dorset. He is also a member of Somerset Council and a Non-Executive Director at HubRx.

Keep ReadingShow less
© Copyright 2025 Garavi Gujarat Publications Ltd & Garavi Gujarat Publications USA Inc